ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

September 2, 1988

Medical Advances Not Driven Entirely By Science, Author Physician Barron Lerner Tells Journalists

March 22, 2002

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014

Zinder Report Implementation, Surgical Conference, On NCAB Meeting June 17-18

May 31, 1974

NCI-Approved Clinical Trials

January 26, 2007